EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Senescence‐Associated Secretory Phenotype (SASP) and Atherosclerotic Plaque Inflammation: Natural Product‐Based Interventions and Implications for Personalized Therapy

Dekun Liu iD, Napamanee Kornthong iD, Shuguang Yu iD, Jakkree Tangthianchaichana, Prasert Sobhon, Sha Yang iD

Cardiology Research and Practice · 2026-01 · 2026 (1)

DOI: 10.1155/crp/6765242 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiology Research and Practice, online erschienen am 10.11.2026. Verfasst von Dekun Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Acupuncture Moxibustion and Tuina Chengdu University of Traditional Chinese Medicine Chengdu 611137 China cdutcm.edu.cn. Die Arbeit nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Thailand Science Research and Innovation, Thammasat University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis underlies most ischemic cardiovascular events, and its prevalence rises with population aging. Cellular senescence is increasingly implicated as a driver of plaque progression, although the causal evidence is largely preclinical. Senescent endothelial cells, smooth muscle cells, and macrophages acquire a senescence‐associated secretory phenotype (SASP), releasing cytokines, chemokines, proteases, and procoagulant factors. These factors sustain plaque inflammation, weaken the fibrous cap, and increase rupture risk. In this narrative review, we link SASP signaling to plaque instability through NF‐κB, p38 MAPK, mTOR, NLRP3, and cGAS–STING signaling. We then evaluate tetramethylpyrazine (ligustrazine), quercetin, fisetin, resveratrol, and curcumin against an operational definition reserving senolytic and senomorphic for effects shown in confirmed senescent cells. On that standard, only quercetin and fisetin qualify; for the other three, the vascular evidence is anti‐inflammatory, antioxidant, or senescence‐preventive rather than directed at established senescent cells. Tetramethylpyrazine protects the endothelial glycocalyx and reduces plaque area in atherosclerotic rabbits. Dasatinib plus quercetin benefits ApoE−/− mice, whereas the only human evidence comes from quercetin monotherapy, which improved endothelium‐dependent vasodilation in vessels from symptomatic male, but not female, bypass patients ex vivo. Because senescence burden varies between individuals, we consider how multiomics profiling might stratify patients. The evidence remains mechanistic and hypothesis‐generating, with limited human cardiovascular interventional data: Much of it was recorded in cells never shown to be senescent, and no formulation has been shown to reach the human vessel wall. Targeting the SASP therefore requires trial evidence rather than an established basis for precision medicine.

Schlagwörter

Stichwörter der Autor:innen

atherosclerosisnatural product senotherapeuticsplaque inflammationsenescence-associated secretory phenotypetetramethylpyrazine

Autor:innen und Institutionen

  • School of Acupuncture Moxibustion and Tuina Chengdu University of Traditional Chinese Medicine Chengdu 611137 China cdutcm.edu.cn.
  • Chulabhorn International College of Medicine Thammasat University Khlong Luang District Bangkok Pathum Thani 12120 Thailand tu.ac.th.
  • Research Unit in Innovative Marine Biotechnology and Natural Bio-Resources for Sustainable Health and Wellness Thammasat University Bangkok Thailand tu.ac.th.
  • Acupuncture and Chronobiology Key Laboratory of Sichuan Province Chengdu 610075 China.
  • Key Laboratory of Acupuncture for Senile Disease (Chengdu University of TCM) Chengdu University of Traditional Chinese Medicine Ministry of Education Chengdu 611137 China meb.gov.tr.
  • Acupuncture Point Effects Key Laboratory of Sichuan Province Chengdu University of Traditional Chinese Medicine Chengdu 611137 China cdutcm.edu.cn.

ORCID-Profile: Dekun Liu, Napamanee Kornthong, Shuguang Yu, Sha Yang

Förderung

  • National Natural Science Foundation of China
  • Thailand Science Research and Innovation
  • Thammasat University

Zitieren

APA

Liu, D., Kornthong, N., Yu, S., Tangthianchaichana, J., Sobhon, P., & Yang, S. (2026). Senescence‐Associated Secretory Phenotype (SASP) and Atherosclerotic Plaque Inflammation: Natural Product‐Based Interventions and Implications for Personalized Therapy. Cardiology Research and Practice, 2026(1). https://doi.org/10.1155/crp/6765242

Vancouver

Liu D, Kornthong N, Yu S, Tangthianchaichana J, Sobhon P, Yang S. Senescence‐Associated Secretory Phenotype (SASP) and Atherosclerotic Plaque Inflammation: Natural Product‐Based Interventions and Implications for Personalized Therapy. Cardiology Research and Practice. 2026;2026(1). doi:10.1155/crp/6765242

BibTeX
@article{Liu2026,
  author = {Liu, Dekun and Kornthong, Napamanee and Yu, Shuguang and Tangthianchaichana, Jakkree and Sobhon, Prasert and Yang, Sha},
  title = {Senescence‐Associated Secretory Phenotype (SASP) and Atherosclerotic Plaque Inflammation: Natural Product‐Based Interventions and Implications for Personalized Therapy},
  journal = {Cardiology Research and Practice},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crp/6765242}
}
Kostenlos starten →